SUMMERCROFT SURGERY
STARTS HILL ROAD, ORPINGTON
HF 4
The percentage of patients with a current diagnosis of heart failure due to LVD who are currently treated with an ACE inhibitor or Angiotensin Receptor Blocker, who are additionally treated with a beta-blocker licensed for heart failure, or recorded as intolerant to or having a contraindication to beta-blockers.
| Indicator | Year | Numerator | Denominator | Ratio | Centile |
|---|---|---|---|---|---|
| HF 4 | 2010 | 7 | 7 | 100.0% | |
| HF 4 | 2011 | 24 | 27 | 88.9% | |
| HF 4 | 2012 | 28 | 31 | 90.3% | |
| HF 4 | 2013 | 26 | 29 | 89.7% | |
| HF004 | 2014 | 9 | 10 | 90.0% | |
| HF004 | 2015 | 14 | 15 | 93.3% | |
| HF004 | 2016 | 18 | 18 | 100.0% | |
| HF004 | 2017 | 21 | 21 | 100.0% | |
| HF004 | 2018 | 18 | 19 | 94.7% | |
| HF004 | 2019 | 39 | 43 | 90.7% | |
| HF004 | 2020 | 33 | 35 | 94.3% | |
| HF006 | 2021 | 35 | 39 | 89.7% | |
| HF006 | 2022 | 33 | 33 | 100.0% | |
| HF006 | 2023 | 32 | 33 | 97.0% |
